Tiny devices based on microfluidics could use bodily fluids to analyze and help treat tumors, said a team of researchers.
The technology, known as microfluidics, promises portable, cheap devices that could not only enable widespread screening for early signs of cancer but also help to develop personalized treatments for patients, said Ciprian Iliescu, a co-author of a review of microfluidic methods for cancer analysis published in the journal Biomicrofluidics, from AIP Publishing.
Pre-Cancerous Lesions
Encyclopedia section of medindia gives general information about Pre Cancerous Lesions
Advertisement
‘The use of fluids as a liquid biopsy, instead of a conventional solid biopsy from a tumor, has many advantages. It is less invasive, reducing patient discomfort, and also provides information about hard-to-access tumors, such as in unborn children.’
Tweet it Now
"If you isolate some cells and expose them to drug candidates, you can predict the response of the patient in advance," said Iliescu, a researcher at IMT-Bucharest in Romania. "Then you can track how the tumor is evolving in response to treatment."
The devices scan blood, saliva or urine for certain cells, proteins or tissue that are produced by tumors and then spread throughout the body.
Because the biological clues, or biomarkers, of cancer end up in the bloodstream, a liquid biopsy can give insights to genomic state of all cancer in the body, including at its primary site and if it has spread. The authors call these insights understanding the "global molecular status of the patient."
![Quiz on Cancer]( "Quiz on Cancer")
Cancer, is the second most leading cause of death worldwide. Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Take this quiz on and test how much you know about cancer.
The biggest challenge is the diversity of cancer. Each of the more than 100 known cancers have their own biomarkers, which the authors classify into four categories: cellular aggregates (circulating tumor microemboli); free cells (circulating tumor cells, circulating endothelial progenitor cells and cancer stem cells); platelets and cellular vesicles (exosomes) and macro- and nanomolecules (nucleic acids and proteins).
A wide range of microfluidic devices are being designed to isolate these biomarkers, leveraging on the boom in nanofabrication in recent decades. Complex structures, such as forked flow channels, pillars, spirals and pools, precisely sieve and control flow rates, while surfaces are lined with molecules that attract specific species. Some devices also use electrical, magnetic or acoustic fields to help select the biomarker target and even have smart, built-in electronic circuits for data processing.
There are already devices on the market, such as CellSearch, which isolate circulating tumor cells. However, more sensitive and faster systems are being developed for many different cancer biomarkers.
Combining more than one method may help with accuracy, although at the cost of speed. Sensitivity can also be improved by culturing the biomarkers to increase their concentration. Iliescu said the field has potential but is still in its infancy.
"We need more and more clinical tests to bring this technology to maturity," he said. ###
Source: Eurekalert
Because the biological clues, or biomarkers, of cancer end up in the bloodstream, a liquid biopsy can give insights to genomic state of all cancer in the body, including at its primary site and if it has spread. The authors call these insights understanding the "global molecular status of the patient."
Quiz on Cancer
Cancer, is the second most leading cause of death worldwide. Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Take this quiz on and test how much you know about cancer.
Advertisement
The biggest challenge is the diversity of cancer. Each of the more than 100 known cancers have their own biomarkers, which the authors classify into four categories: cellular aggregates (circulating tumor microemboli); free cells (circulating tumor cells, circulating endothelial progenitor cells and cancer stem cells); platelets and cellular vesicles (exosomes) and macro- and nanomolecules (nucleic acids and proteins).
A wide range of microfluidic devices are being designed to isolate these biomarkers, leveraging on the boom in nanofabrication in recent decades. Complex structures, such as forked flow channels, pillars, spirals and pools, precisely sieve and control flow rates, while surfaces are lined with molecules that attract specific species. Some devices also use electrical, magnetic or acoustic fields to help select the biomarker target and even have smart, built-in electronic circuits for data processing.
There are already devices on the market, such as CellSearch, which isolate circulating tumor cells. However, more sensitive and faster systems are being developed for many different cancer biomarkers.
Combining more than one method may help with accuracy, although at the cost of speed. Sensitivity can also be improved by culturing the biomarkers to increase their concentration. Iliescu said the field has potential but is still in its infancy.
"We need more and more clinical tests to bring this technology to maturity," he said. ###
Source: Eurekalert
Personalized Medicine
Personalized medicine is an advanced method to predict risk of a human to a disease and its early treatment. It is tailor-made precision medicine with least side effects. Pharmacogenomics is the novel concept based on which personalized medicine is designed.
Advertisement
 World Cancer Death ClockWorld Cancer Death Clock is a dynamic calculator that constantly updates the number of people in the world dying due to various cancers. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
Drugs known as glucagon-like peptide-1 receptor agonists, prescribed for type 2 diabetes, could lower the likelihood of developing colorectal cancer.
Researchers found a pathway linked to allergies that, when blocked, triggers antitumor immunity in lung cancer mouse models.
The occurrence of epimutations early in pregnancy challenges traditional theories related to carcinogenesis and the risk of developing breast cancer.
More affected relatives, higher lung cancer risk; participants with affected mothers or siblings faced increased risk.
Colorectal cancer can be lowered by up to 7% by increasing dietary consumption of folate rich foods like spinach, broccoli or taking folate supplements.